BioTech Social Media and Updates

Startup Pitches Brainless Human Clones for Organ Harvesting
SocialApr 8, 2026

Startup Pitches Brainless Human Clones for Organ Harvesting

Big news about a startup called R3 Bio that plans to create brainless human clones for the sole purpose of harvesting organs when people need them. They are just pitching the idea to investors now, but it is pretty wild (if...

By Bertalan Meskó, PhD
Tiny AI Startup Outpaces Big Labs, Accelerates Discovery
SocialApr 8, 2026

Tiny AI Startup Outpaces Big Labs, Accelerates Discovery

I met with the founders of https://t.co/VDKFa8U1Su today. Building an AI scientist. About to launch something new that is beating all the evaluations. Their AI is next level. Evolves faster than competition that got a lot more money. Has a better memory. And...

By Robert Scoble
Lithium Reverses ApoE4 Cellular Deficits, Merits AD Trials
SocialApr 8, 2026

Lithium Reverses ApoE4 Cellular Deficits, Merits AD Trials

https://t.co/r6JzHA1RxM with ApoE4/E4 from a sporadic Alzheimer's disease patient "Given the drug's demonstrated efficacy in reversing ApoE4-driven cellular vulnerabilities, lithium salt warrants further investigation for the treatment of AD." https://t.co/r6JzHA1RxM https://t.co/v2lE0XhN7n

By David Barzilai, MD PhD
Prediction Markets Could Overtake Biotech Stocks for Phase‑3 Bets
SocialApr 8, 2026

Prediction Markets Could Overtake Biotech Stocks for Phase‑3 Bets

I think that one day soon that prediction markets are going to replace biotech stocks for how investors play key readouts...especially wrt larger companies. For example, if Novartis has a big phase 3, isn't it more interesting and efficient to...

By Brad Loncar
Targeting Liver ApoE Boosts Bone Healing in the Elderly
SocialApr 8, 2026

Targeting Liver ApoE Boosts Bone Healing in the Elderly

Neutralizing hepatic apolipoprotein E enhances aged bone fracture healing "Our work here identifies novel liver-to-bone cross-talk and a noninvasive, translatable therapeutic intervention for aged bone regeneration" https://t.co/KSzvkKOzZt https://t.co/1p0cXQlalT

By David Barzilai, MD PhD
Α‑Eleostearic Acid Acts as Senolytic via Ferroptosis
SocialApr 8, 2026

Α‑Eleostearic Acid Acts as Senolytic via Ferroptosis

α-eleostearic acid as a senolytic via ferroptosis. Found in high concentrations in Tung oil (which is toxic) and in small amounts in Bitter Melon oil. https://t.co/FSCix3OZtD

By Peter Suzman
Turmeric‑Ginger Coating Doubles Bone Bonding, Cuts Bacteria, Cancer Cells
SocialApr 7, 2026

Turmeric‑Ginger Coating Doubles Bone Bonding, Cuts Bacteria, Cancer Cells

Turmeric and ginger extract applied to titanium implants can double bone bonding in six weeks, eliminate 92% of surface bacteria, and sharply reduce cancer-causing cells, offering a promising advance for joint replacement and bone cancer patients. biomaterials

By Phys.org Threads
Plant Tissue Culture Constantly Reveals Surprising Cellular Tricks
SocialApr 7, 2026

Plant Tissue Culture Constantly Reveals Surprising Cellular Tricks

Coolest part of plant tissue culture is that no matter how much experience you have, you will always learn something new about the strange things plant bits do when given some molecular encouragement.

By Sebastian Cocioba
Conjugated PUFAs Target Senescent Cells
SocialApr 7, 2026

Conjugated PUFAs Target Senescent Cells

Polyunsaturated lipid senolytics exploit a ferroptotic vulnerability in senescent cells “ Conjugated PUFAs α-ESA and its methyl ester selectively eliminate diverse senescent cells… These lipid senolytics reduce tissue senescence and extend health span in aged mice” 👉 Lipid peroxidation underlies selective vulnerability...

By David Barzilai, MD PhD
Hair‑Loss Pill Redefines Masculinity and Aging
SocialApr 7, 2026

Hair‑Loss Pill Redefines Masculinity and Aging

The Hair-Loss Drug Rewriting the Rules of Masculinity A pill to cure baldness is changing the way men age — and how they see themselves. https://t.co/4OiLpmOwGR https://t.co/YQLBx61gVT

By David Barzilai, MD PhD
Follistatin: Dual Weapon Against Cancer and Muscle Loss
SocialApr 7, 2026

Follistatin: Dual Weapon Against Cancer and Muscle Loss

Follistatin protein, which plays a key role both in inhibiting tumors and promoting muscle tissue growth. https://t.co/OebCo6FSI7

By Liz Parrish
KLF5 Drives Pancreatic Cancer Spread via Gene Rewiring
SocialApr 7, 2026

KLF5 Drives Pancreatic Cancer Spread via Gene Rewiring

A gene called KLF5 may be a key force behind the spread of pancreatic cancer—but not in the way scientists expected. Rather than mutating DNA, it rewires how genes are turned on and off, helping tumors grow and invade new...

By Liz Parrish
Fatty Acids Target and Eliminate Aging “Zombie” Cells
SocialApr 7, 2026

Fatty Acids Target and Eliminate Aging “Zombie” Cells

NEW STUDY finds certain fatty acids selectively kill senescent "zombie" cells. The molecules exploit a fundamental biophysical weakness in senescent cells, a totally new approach. Could we simply consume these moleculs to treat aging? ...🧵 https://t.co/EceCAfdlvz

By David Sinclair, PhD
Shingles Vaccine Beats Geroscience in Reducing Dementia
SocialApr 7, 2026

Shingles Vaccine Beats Geroscience in Reducing Dementia

a different take: the shingles vaccine lowers dementia and all cause mortality and it’s targeted to a specific virus, not the process of aging so far the data say the score is shingles vaccine 1, geroscience hypothesis 0 and I could say the...

By Charles Brenner, PhD
New Cytotoxic Targets Unveiled at AACR26
SocialApr 7, 2026

New Cytotoxic Targets Unveiled at AACR26

Time to head off the beaten track at #AACR26 with our latest preview exploring novel targets and cytotoxics. The long climb up the hill may be worth it for some of them: https://t.co/l9tkdWvpuF https://t.co/M5B3RTW1wf

By Sally Church
Funding Hurdles Stall Needed Multi‑site BPC‑157 Trial
SocialApr 7, 2026

Funding Hurdles Stall Needed Multi‑site BPC‑157 Trial

I can’t see any reason why a proper multi site RCT of BPC157 done by a few independent groups wouldn’t help clarify any real vs placebo effects. The challenge: no one wants to pony up the $ (more like $$$$...

By Andrew Huberman – Huberman Lab
Blueprint for Integrating Psilocybin Into NHS Mental Health Care
SocialApr 7, 2026

Blueprint for Integrating Psilocybin Into NHS Mental Health Care

British Journal of Psychiatry Psychedelics in NHS services: exploring a model for real-world implementation of psilocybin https://t.co/6sgfqg66rt

By Julie Holland
First Human Trial Tests Cellular Age Reversal Therapy
SocialApr 7, 2026

First Human Trial Tests Cellular Age Reversal Therapy

This method to reverse cellular ageing is about to be tested in humans A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely refresh aged tissues and organs. 💡"Technologies to refresh ageing tissue...

By David Barzilai, MD PhD
US Obesity Rates Dip in 2023, Drug Impact Suspected
SocialApr 7, 2026

US Obesity Rates Dip in 2023, Drug Impact Suspected

BMI and obesity prevalence in the US decreased in 2023 for the first time in more than a decade. What s the reason? Are people 'exercising more and eating less' or are GLP-1 agonists starting to have an effect? https://jamanetwork.com/journals/jama-health-forum/fullarticle/2827712 @GatlanHealth

By Robert Lufkin, MD
Gilead's $3.1B Deal Expands ADC Portfolio
SocialApr 7, 2026

Gilead's $3.1B Deal Expands ADC Portfolio

Gilead continues M&A surge with $3.1B deal for ADC specialist Tubulis https://t.co/xEMXvDq2LL by @gwendolynawu $GILD #biotech

By Ben Fidler
Top Experts Discuss Cutting‑Edge Longevity Strategies Live
SocialApr 7, 2026

Top Experts Discuss Cutting‑Edge Longevity Strategies Live

Fund Longevity Live Stream Wednesday, April 8 11:00 AM - 12:00 PM EDT 🔗 https://t.co/gNCkMYxhfI @aubreydegrey — Combination therapy @LidskyPeter — New theory of aging Alexander Panchin — Gene therapy & science communication @longevion — Crypto & funding @cordeiro — Global longevity movement @ILAISRLA ...

By David Barzilai, MD PhD
Accelerating Early-Onset Cancer Cause Research for Prevention
SocialApr 7, 2026

Accelerating Early-Onset Cancer Cause Research for Prevention

Accelerating discovery of cancer causes for prevention in the era of rising early-onset cancers 🌟This roadmap aims to stimulate advances to accelerate cancer etiology research and prevention in the era of rising early-onset cancers. https://t.co/d0z6EHDpTh https://t.co/H6I76e4tFB

By David Barzilai, MD PhD
Peptide Vials Contaminated, Underdosed, and Unsafe
SocialApr 7, 2026

Peptide Vials Contaminated, Underdosed, and Unsafe

Besides the lack of data for safety or efficacy on peptides, or any assurance of sterility, here's what an independent lab found of samples: —The vial of BPC-157 contained lead —The vial of TB-500 contained endotoxins —The vial of CJC-1295 contained <42% of...

By Eric Topol
Fund NIH Trials to Validate Unapproved Peptide Safety
SocialApr 7, 2026

Fund NIH Trials to Validate Unapproved Peptide Safety

I thought this was an excellent, balanced article on the current state of unapproved peptides from a safety and regulatory perspective by @AnjeanetteDamon in @propublica https://t.co/DbA8cdvTY5 The fundamental problem is that we don't have quality data on safety or efficacy for...

By Matt Kaeberlein, PhD
SNY's Atopic Dermatitis Candidate Fails; NKTR Rem
SocialApr 7, 2026

SNY's Atopic Dermatitis Candidate Fails; NKTR Rem

$SNY next-gen atopic dermatitis drug failed in P2b. Missed primary endpoint. MOA was IL13xTSLP. Now what have they got to follow up dupi if (when?) they discontinue amlitelimab? $NKTR 👀 🤷🏻‍♂️ Remains the only new MoA...

By Adam May
Stay Grounded Amid Rapid Bioinformatics Advances
SocialApr 7, 2026

Stay Grounded Amid Rapid Bioinformatics Advances

🧵Bioinformatics evolves fast. New tech. New data. New analysis. But here's how to stay grounded and not get overwhelmed: https://t.co/VdWFpeE93W

By Ming Tang
CEO Kazimi Explores Computation, Chemistry, Culture in Drug Discovery
SocialApr 7, 2026

CEO Kazimi Explores Computation, Chemistry, Culture in Drug Discovery

Computation, Chemistry & Culture for Drug Discovery: Nimbus Therapeutics CEO Abbas Kazimi is the latest guest on The Long Run. Sponsored by @AlphaSenseInc and Dash Bio. https://t.co/XCysW6El1o

By Luke Timmerman
Tubulis Secures $5B Gilead Acquisition After CEO Vision
SocialApr 7, 2026

Tubulis Secures $5B Gilead Acquisition After CEO Vision

Last year I visited @Tubulis_GmbH in Munich, Germany. Here's what CEO Dominik Schumacher told me they were aiming to do. Congrats on today's acquisition by @gilead for up to $5B, and congrats to @schroederthilo who raved to me about this...

By Brad Loncar
Four‑Month MDF Cuts NAFLD Liver Fat by 24%
SocialApr 7, 2026

Four‑Month MDF Cuts NAFLD Liver Fat by 24%

"The 4-month intervention with this MDF was effective in reducing IHTC in patients with NAFLD by an absolute reduction of −5.89% and a relative reduction of −24.30% after adjusting for weight loss. Such effect was partly mediated by altered composition...

By David Barzilai, MD PhD
Real Progress Lies in 0‑to‑PCC Data, Not AI Hype
SocialApr 7, 2026

Real Progress Lies in 0‑to‑PCC Data, Not AI Hype

Check out my article in @FastCompany on AI drug discovery revolution. From one perspective, it may feel like I am turning into a version of Derek Lowe - AI skeptic. And when I read another interview with the IT...

By Alex Zhavoronkov, PhD
Gene Therapy Poised to Redefine Obesity Treatment Landscape
SocialApr 7, 2026

Gene Therapy Poised to Redefine Obesity Treatment Landscape

1/GLP-1 obesity and weight-loss drugs - such as $NVO Ozempic & Wegovy and $LLY Zepbound & Mounjaro have long become a household name - making Obesity the fastest growing market in the BioTech and Pharma ecosystem and generating unprecedented revenues....

By Yair Einhorn
Probability of Success Integrates Development Risk Into Biotech Valuations
SocialApr 7, 2026

Probability of Success Integrates Development Risk Into Biotech Valuations

Incorporating Probability of Success (PoS) is a unique aspect of #biotech valuation investors must be aware of. It tries to factor development risk into revenue and cost assumptions. Here is a table of PoS values: #learnbiotechinvesting #investing #BiotechPrometheus https://t.co/GA3LVSmWFZ

By Biotech Investor
Bootstrapped Cryo‑AI: LLMs Power Life‑Saving Freeze Tech
SocialApr 7, 2026

Bootstrapped Cryo‑AI: LLMs Power Life‑Saving Freeze Tech

Meet Dr. Mark Woodward, undergrad and grad from Stanford, PhD from Harvard, Many years at Google as part of Google brain. One day he realizes that we need the enabling technology to pause biological time for patients that are about...

By Alex Zhavoronkov, PhD
Digital Twins Simulate Psychedelic Effects for Consciousness Disorders
SocialApr 7, 2026

Digital Twins Simulate Psychedelic Effects for Consciousness Disorders

Digital twins allow virtual clinical trials of psychedelics for disorders of consciousness 🧠↔🧠 | Innovation | Tech for Good. 💬 Using magnetic resonance imaging (MRI), scientists have developed personalized, whole-brain computational models of patients with disorders of consciousness. Using these...

By Efi Pylarinou
AI Meets Drug Discovery at NYC Meetup Tuesday
SocialApr 7, 2026

AI Meets Drug Discovery at NYC Meetup Tuesday

AI x Drug Discovery meetup next Tues (14) in NYC ! @ginkgo excited to host with @AAlphaBio — sign up here : https://t.co/GG5c7F4ogO

By Jason Kelly
3D‑Printed Spanlastics Directly Target Tumors, Cut Side Effects
SocialApr 6, 2026

3D‑Printed Spanlastics Directly Target Tumors, Cut Side Effects

3D-printed spanlastics, microscopic carriers for cancer drugs, show potential to target tumors directly and reduce side effects by concentrating therapy at the tumor site rather than throughout the body. nanotechnology

By Phys.org Threads
Biotech M&A Poised for Second‑Busiest Year, Early Deals Surge
SocialApr 6, 2026

Biotech M&A Poised for Second‑Busiest Year, Early Deals Surge

Biotech M&A on track to have 2nd most active year in history w/ more early stage deals. Nice summary of which funds have benefited from recent M&A from Stifel @TimOpler $XBI $IBB https://t.co/udCuhIcaIi

By Daphne Zohar
Creating Autonomous Health via Real-Time Multi‑Omic Monitoring
SocialApr 6, 2026

Creating Autonomous Health via Real-Time Multi‑Omic Monitoring

I've measured my body a lot. I'm about to dwarf what we've done by building real-time continuous multi-omic monitoring and intervention. Cars drive themselves. Software writes itself. I'm building Autonomous Health. First for me, then for you. > Peptides...

By Bryan Johnson
One Psychedelic Dose Quickly Eases Depression, Trial Shows
SocialApr 6, 2026

One Psychedelic Dose Quickly Eases Depression, Trial Shows

Single dose of a psychedelic drug can rapidly reduce depressive symptoms, clinical trial suggests https://t.co/c72qpfwQPm https://t.co/xR7hbj4v8e

By David Barzilai, MD PhD
Repurposing Approved Drugs: Small Trials Explore New Uses
SocialApr 6, 2026

Repurposing Approved Drugs: Small Trials Explore New Uses

Great reporting from @Philanthropy on our grantee @CuresWReach, which runs small trials testing whether existing, approved drugs might work for entirely different diseases.

By Alexander Berger
AI Cancer Vaccines Thrive While Cities Reject Data Centers
SocialApr 6, 2026

AI Cancer Vaccines Thrive While Cities Reject Data Centers

incredible seeing (actual, live) AI-designed cancer vaccines one minute, and local city councils unanimously voting down data centers the next. cognitive dissonance.

By Kanyi Maqubela
Egg Bioreactors Replace CHO Cells in Biologics Production
SocialApr 6, 2026

Egg Bioreactors Replace CHO Cells in Biologics Production

We’ve optimized drug design with AI. Why are we still manufacturing with CHO like it’s the 1980s? Neion Bio is rethinking biologics production using chicken eggs as bioreactors. Excited to hear Sam Levin at #SynBioBeta2026. Visit the SynBioBeta website to read the full...

By John Cumbers
Autonomous Labs Revolutionize Research: Insights From Ginkgo, OpenAI, PNNLab
SocialApr 6, 2026

Autonomous Labs Revolutionize Research: Insights From Ginkgo, OpenAI, PNNLab

awesome talk about Autonomous labs from @Ginkgo, @OpenAI, and @PNNLab ! Check it out 👇

By Jason Kelly
Study Shows Subcutaneous Tepezza Matches Infused Version
SocialApr 6, 2026

Study Shows Subcutaneous Tepezza Matches Infused Version

Under-the-skin Tepezza comparable to infused version in key study, Amgen says https://t.co/rOQqbRmEpL $AMGN $VRDN - 25%

By Ben Fidler
Immune Training Against Senescent Cells Reduces Tumor Growth
SocialApr 6, 2026

Immune Training Against Senescent Cells Reduces Tumor Growth

Here's my take on your paper: Cellular senescence or "zombie cell" events happen when a cell experiences too much genetic or epigenetic noise, caused by cellular damage (e.g. DNA breaks) or telomere erosion Your study of a Lewis Lung Carcinoma (LLC) mouse...

By David Sinclair, PhD
Diabetes Drug Replicates Exercise Effects in Prostate Cancer Patients
SocialApr 6, 2026

Diabetes Drug Replicates Exercise Effects in Prostate Cancer Patients

How a Diabetes Drug May Echo the Benefits of Exercise in Prostate Cancer Care “From a clinical standpoint, seeing a metabolic signal that mirrors what we associate with intense exercise was striking… For patients whose treatments or symptoms limit physical activity,...

By David Barzilai, MD PhD
Resveratrol Alters Sperm Epigenetics, Boosts Offspring Metabolism
SocialApr 6, 2026

Resveratrol Alters Sperm Epigenetics, Boosts Offspring Metabolism

CRAZY IF TRUE PAPER: A new study in mice reports that resveratrol intake by old male mice (or directly treating their sperm) changes the metabolism of embryos & pups, "potentially through alterations in sperm telomere length and epigenetic modifications"...

By David Sinclair, PhD
Meta-Analyses Reveal Psychedelics Boost Brain Circuits
SocialApr 6, 2026

Meta-Analyses Reveal Psychedelics Boost Brain Circuits

Two systematic, meta-analyses on psychedelic drugs today Brain Circuit Function @NatureMedicine https://t.co/nBmjreYEXU Depression @NatMentHealth https://t.co/zJR06AsC0Z https://t.co/qpWdjzBR4D

By Eric Topol
Cell Senescence Drives Cancer Risk, Yet Can Be Modulated
SocialApr 6, 2026

Cell Senescence Drives Cancer Risk, Yet Can Be Modulated

Cell senescence and how it predisposes to cancer, no less how we may be able to modulate it. An outstanding @CellCellPress review https://t.co/bmAXOS1Ybz

By Eric Topol